# OnCo record abbott-realtime-idh2 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/abbott-realtime-idh2/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "abbott-realtime-idh2" ;
  schema:name "Abbott RealTime IDH2"@en ;
  schema:description "The FDA-approved test that finds an IDH2 mutation in acute myeloid leukaemia, the gateway to enasidenib."@en ;
  schema:url <https://onco.cc/drugs/abbott-realtime-idh2/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P170005>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "PCR companion diagnostic test (IDH2 mutations, blood or bone marrow)" ;
  schema:alternateName "Abbott RealTime IDH2" ;
  onco:approval "US 2017: Companion diagnostic for enasidenib in acute myeloid leukaemia (IDH2 R140 and R172 mutations)" ;
  onco:related <https://onco.cc/drugs/abbott-realtime-idh1/>, <https://onco.cc/biomarkers/idh2-mutation/> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/enasidenib/> ;
  onco:companies <https://onco.cc/companies/abbott/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/companion-diagnostic-term/> .